Yun-Ju Ruby Huang

Title: Yun-Ju Ruby Huang: Innovator in Cancer Patient Stratification

Introduction

Yun-Ju Ruby Huang is a notable inventor based in Singapore, recognized for her contributions to cancer research and patient stratification. With a focus on improving clinical outcomes for cancer patients, her work has significant implications for personalized medicine.

Latest Patents

Yun-Ju Ruby Huang holds a patent titled "Patient stratification and determining clinical outcome for cancer patients." This invention outlines a method for classifying cancer in individual patients to estimate their clinical outcomes. It specifically addresses the estimation of clinical outcomes for patients suffering from epithelial ovarian cancer (EOC). Additionally, the patent discusses how the epithelial mesenchymal score of a cancer patient can be altered by administering an EMT reversal agent, thereby increasing the patient's susceptibility to anti-cancer treatments.

Career Highlights

Throughout her career, Yun-Ju Ruby Huang has worked with esteemed institutions such as the Agency for Science, Technology and Research and the National University of Singapore. Her roles in these organizations have allowed her to contribute significantly to the field of cancer research and patient care.

Collaborations

Yun-Ju Ruby Huang has collaborated with notable colleagues, including Jean Paul Thiery and Kian Ngiap Chua. These partnerships have further enhanced her research and innovation in cancer treatment methodologies.

Conclusion

Yun-Ju Ruby Huang's work in cancer patient stratification exemplifies the importance of innovation in healthcare. Her patent and career achievements reflect her commitment to improving clinical outcomes for cancer patients.